TLC Announces Development and License Agreement with Birdie Biopharmaceuticals for NanoX…
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet…
Read More...
Read More...
